The following investigation was carried out with a tumour strain which can be propagated continuously in mice and in rats. The strain was sent, in 1929, to Professor de Balogh of the Pathological and Cancer Research Institute of the University in Budapest by Professor Silverstein of the Pathological Institute of the University of Vienna. It was then a transplantable mouse tumour, and was described as "Ehrlich's mouse carcinoma." It is one of the most rapidly, if not the most rapidly, growing of transplantable tumours, and on inoculation into mice takes in 100 per cent. Histologically, it is a very cellular tumour, without any definite structure, and composed of undifferentiated round cells. After several unsuccessful attempts, I was able, in 1929, to transplant this tumour into rats, and it has been propagated continuously in rats since. Detailed accounts of these experiments have been published (Putnoky, 1930 (Putnoky, , 1933 , but a brief account of the technique of transplantation and of the behaviour of the tumour in rats is necessary.
The success of the propagation in rats depends mainly on the use of large doses. In my experiments, I use from 300 to 500 mg. of tumour. The material is inserted subcutaneously through an incision in the skin of the back and pushed into a pocket of subcutaneous tissue as distant from the incision as possible. Dr. W. Cramer, to whom I sent several rats with this tumour in 1935, informs me that he has been able to propagate this tumour continuously in rats through 16 generations, using smaller amounts of tumour tissue, from SO to' 100 mg. The tumour has to be transplanted every ten days, but it is not necessary to transplant into very young rats. As a rule, rats weighing 100 to 120 grams were used. The strain of rat appears to be of some importance. In the Budapest rats the tumour grows so rapidly that in ten to fourteen days it attains a weight varying from 30 to 40 grams, and in that period kills a high percentage of the tumour-bearing animals as shown by the following In my experiments carried out in the Laboratories of the Imperial Cancer .Research Fund two different strains of rats were used: the Wistar strain and a strain bred from rats especially susceptible to the Jensen rat sarcoma. In both these strains the tumour gives 100 per cent of takes and shows a rapid growth during the first ten days; it then begins to become necrotic in the centre, and eventually regresses. In these strains of rats the tumour rarely killed the animals. This difference may be due to differences in the diet on which the rats are kept in the two Institutes.
Histologically, the tumour growing in rats does not differ materially from the tumour growing in mice. In spite of the fact that the tumour had been propagated for seven years continuously in rats, inoculation of small pieces into mice produced tumours in 100 per cent of the inoculated animals. Up to now, heterotransplantation of malignant tumours has been successful only through one or at the most a few generations, and then as a rule only in very young animals. The rat strain of the Ehrlich carcinoma is, therefore, the first example of a heterotransplantation continued over many years. As already stated, very young rats are not necessary to ensure successful propagation. This rat-grown strain may, therefore, now be considered to be a separate sub-strain of the Ehrlich mouse carcinoma.
A number of interesting questions arise.
( 1) Is the tumour now composed of rat cells, or still of mouse cells? (2) If the tumour still consists of mouse cells, have these cells been altered in any way as the result of having been propagated over many years in the environment of a different species?
(3) If it is still a mouse tumour, to what extent do the phenomena of induced resistance or immunity, which have so far been studied in homotransplantations, apply to heterotransplantations?
To simplify the descriptive account, the term" mouse strain" will be used in this paper for the tumour propagated in mice; and" rat strain" for the tumour propagated continuously in rats.
If the rat strain is transferred from rats to mice, it takes in 100 per cent even if small pieces, such as are used in the routine method of transplanting a mouse tumour to mice or rat tumours to rats, are inoculated. In mice it grows rapidly and progressively, and never regresses spontaneously. As already stated, the successful transplantation of the rat strain from rat to rat is possible only with very large doses. This shows that the mouse organism presents a more favourable environment for the rat strain than the rat organism, a fact which indicates that the cells of the rat strain tumours are still mouse cells.
Further evidence bearing on this point was obtained by investigating whether, and how, rats could be made resistant or immune to the transplantation of the rat-strain tumour. In 1907, Bashford, Murray and Cramer showed that the homotransplantation of tumours, i.e. transplantation within the same species, could be prevented partially or entirely by a previous inoculation of normal embryonic tissues of the same species (" homologous embryonic tissues"), or by the inoculation of tumour tissue of the same species (" homologous tumour tissues") which either failed to take or after a temporary growth regressed. This phenomenon, described as "resistance" or "immunity" to transplantation, has since been the subject of numerous investigations which have been reviewed in two excellent articles by Woglom (1913 Woglom ( ,1929 ; while the technique has been described by Cramer (1932) . For further details the reader is referred to these articles. For the purpose of this investigation it is sufficient to say that a preliminary treatment with homologous normal embryo skin, i.c. skin of the same species, is the most efficient method for inducing a resistance to the transplantation of tumours. The resistance is more effective against tumour strains which grow slowly and do not take in all the inoculated mice than against rapidly growing strains which take in 90 to 100 per cent; and observations are recorded on tumour strains with an exceptionally vigorous growth for which no resistance to transplantation could be induced by previous treatment with homologous embryo skin. The resistance appears ten days after the inoculation of the homologous tissue-either embryo skin or homologous tumour tissue-and persists over many weeks. Normal embryo skin or tumour tissue from a different species, even from a closely related one, is either much less effective or quite ineffective.
If, therefore, the malignant cells of the rat-strain tumour were now rat cells, it should be possible to make rats resistant against the successful transplantation of this rat strain, by a previous inoculation with normal rat cells (rat embryo skin) or malignant rat cells (transplanted rat tumours which had regressed); while a previous inoculation with normal or malignant cells from the mouse should not induce a resistance against the transplantation of the rat strain. As will be seen presently, exactly the reverse takes place. A number of other similar experiments were carried out subsequently. Altogether 45 series of such immunity experiments were performed.
In all these experiments the procedure was the same. A certain number of animals (rats or mice) received a "preliminary inoculation" of either homologous or heterologous normal tissue (embryo skin), or of heterologous tumour tissue, in doses of 0.05 c.c. for mice and 0.3 c.c. for rats. An equal number of animals were kept as controls, receiving no preliminary inoculation. Ten days after this preliminary treatment, all the animals were inoculated with the same tumour strain: "test inoculation." The growth of the tumour used in the test inoculation was then charted in weekly periods. If there was no difference in the rate of growth and the number of successful takes of the tumour given in the test inoculation, the result is recorded as "no immunity"; while a marked difference in rate of growth and successful takes is recorded as "immunity." In order to simplify and abbreviate the records of our experiments they are grouped together ill LillI. form, and for some of these experiments the charts giving the rate I Ii growth and number of successful takes are also reproduced. The growl h IIf the .control tumours is always given on the right hand side of each ch.m .
In all the Tables, the first column (\fgfvt.:~·the protocol number of the experiment and species of animal use.l: the second column (B) the material used for the preliminary inoculation; 1111' tltrd column (C) the tumour strain used for the test inoculation; and till' ffhirtth '(Iolumn (D) the result, "immunity" or "no immunity." In t h(~, 41arts, each number represents an 
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•• PI.ATE fA animal; the black silhouettes represent the size of the tumour obtained after the test inoculation in weekly chartings. Table I a number of experiments are collected in which the rat strain of the Ehrlich carcinoma was inoculated into rats as the test inoculation. Immunity was produced when mouse cells, whether normal or malignant, were used for the preliminary inoculation, but not when either normal or malignant rat cells were used. One experiment (No. 16) which gave a divergent result is included. In this experiment the preliminary inoculation with the Jensen rat sarcoma produced an immunity; but in two similar experiments (Nos. 14 and 15) it failed to do so. For comparison, two experiments are included (No. 22) which illustrate the typical immunity reaction for homotransplantation. A true rat tumour-the Walker rat carcinoma-was used for the test inoculation. In this experiment a preliminary treatment with a rat tumour (J. R. S.) produced immunity, while a mouse tumour (Ca. 63) failed to do so. Some of the experiments represented in Table I are illustrated by the charts given in Plates I and IA.
According to these immunity reactions, the behaviour of the cells of the strain grown continuously in rats is still that of mouse cells, and not of rat cells.
In order to obtain further information on this point, experiments were carried out in which the. rat strain was inoculated into mice. As already stated, the rat strain grows as readily in mice, even with small doses, as the mouse strain. If the rat strain consisted of rat cells, it should be possible to induce resistance against its transplantation into mice by a preliminary treatment with rat cells. No immunity was obtained by such a preliminary treatment, as shown in Experiments 12 and 13, Table II. Table II contains, in addition, a number of experiments illustrating the behaviour of the mouse strain in mice subjected to a preliminary treatment with mouse cells or with rat cells. As already stated, the mouse strain grows so vigorously in mice that it is difficult to produce a resistance to it in these animals. Mouse embryo skin given in a dose sufficient to make mice resistant to the transplantation of most transplantable tumours failed to produce an immunity against the Ehrlich mouse carcinoma, and even after the dose of mouse embryo skin was trebled only a slight degree of immunity was elicited. The charts reproduced in Plate II are added as illustrations to Table II. These series of experiments demonstrate again that the organism of a mouse is so favourable an environment for both the rat and the mouse strain that it is not possible to produce a resistance against the transplantations of these two strains into mice either by rat embryo skin or by mouse embryo skin. The organism of the rat, on the other hand, offers a less favourable environment, and can be made resistant against the rat strain by treatment with mouse embryo skin, but not by treatment with rat embryo skin. If the cells of the rat strain were biologically rat cells, treatment with mouse embryo skin should not be able to induce resistance when treatment with rat embryo skin fails to do so. The argument from these immunity experiments, 
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therefore, again leads to the conclusion that the rat strain is stil] composed essentially of mouse cells. In homologous transplantation, the production of an Hf~ctive im'ftunity depends, as has already been stated, on the use oj homologous chyma or homologous to the host. The results show clearly that for this particular tumour strain an immunity against heterologous transplantation can be produced only by tissue homologous to the tumour parenchyma-in this case mouse tissue-s-and not by tissue homologous to the host. This conclusion is in agreement with the observations of Purdy on the heterotransplantation of fowl tumours into ducks. He found that resistance was conferred upon ducks by a previous inoculation of fowl embryo, but not of duck embryo. In Purdy's experiments, however, the tumours were undoubtedly fowl tumours; they had grown continuously in fowls, and were taken from fowls for the test inoculation into ducks. The experiments reported so far are concerned with the study of the changes produced in the rat organism by inoculations of homologous (rat) and heterologous (mouse) tissue, both normal and cancerous, using as the test object a tumour of heterologous (mouse) origin which has the exceptional property of continued propagation in rats. Another group of experiments was carried out to investigate the reverse problem, namely, the changes produced in the organism of the rat by inoculation of this exceptional tumour of heterologous origin, using as the test object transplantable rat tumours, i.e. of homologous origin.
Two transplantable rat-tumour strains were used: the Walker rat carcinoma and the Jensen rat sarcoma.
As already stated, in rats inoculated with large doses (0.3-0.5 gm.) of the rat strain of the Ehrlich carcinoma the tumour grows rapidly for the first ten days and reaches a considerable size, about 30 gm. It then begins to become necrotic and undergoes spontaneous absorption. As was to be expected, such rats are now completely resistant to a second inoculation of this tumour. But it was surprising to find that they are also resistant to the inoculation of the two tumours of rat origin-the Jensen rat sarcoma and the Walker rat carcinoma. If instead of the rat strain of the Ehrlich carcinoma a large dose of the mouse strain is used for the preliminary inoculation, which also produces a temporary growth followed by absorption, only a slight degree of immunity is induced. The experiments bearing on this point are collected in Table III, oculation the preliminary treatment with the rat strain had made the rats resistant in three experiments, and had failed to do so in only one (No. 39), in which the Jensen rat sarcoma did not grow well in the controls. It is surprising that even the mouse strain of the Ehrlich tumour, which undoubtedly consists of mouse cells, has in these experiments produced in rats a slight but definite degree of resistance to the transplantation of such tumours as the Walker rat carcinoma and the Jensen rat sarcoma, which undoubtedly consist of rat cells. This is, perhaps, due to the fact that even the mouse strain of the Ehrlich tumour grows in rats to a considerable size before it regresses, so that the amount of tissue absorbed is very large, from 10 to 20 gm., whereas the amount of tissue used in the preliminary inoculation with mouse embryo skin or mouse tumours is much smaller--Q.OS c.c, as a rule. Whatever may be the correct explanation of this effect, there is a very pronounced difference between the immunizing action of the mouse strain and the rat strain of the Ehrlich tumour, the rat strain behaving as an immunizing agent in rats towards rat tumours, more like a rat tumour than the mouse strain. This is a phenomenon of general biological interest, since it indicates that the cells of this tumour strain, which are originally of mouse origin, and which in their general biological behavior and in their reactions in rats immunized with mouse tissue still retain their character of mouse cells, have undergone an alteration as the result of the prolonged and continued propagation in rats. In adapting themselves to the rat environment, they have acquired some of the properties of rat cells.
Against this interesting conclusion an objection may be raised. When a tumour is transplanted from one animal to another, the tumour cells themselves continue to live in the new host, but the stroma degenerates and a new stroma is provided by the new host. In a successful heterologous transplantation of a tumour consisting of mouse cells into rats, the resulting tumour consists, therefore, partly of mouse cells; but in so far as the stroma is provided by rats it also consists partly of rat cells. When such a tumour has regressed, both the inoculated mouse tumour cells and the inoculated rat stroma cells have been absorbed, and, it may.be. argned that the condition of resistance induced by the regressionof sucha tumour is due to the absorption of the rat cells of the i~il~a:te,cJ'str_Dma and notof. the tumour cells, which are of mouse origin. The 'validitY:'of this argument tan be tested in the following manner:
; " If the mouse strain of the Ehrlich tumour rshioculated into rats in sufficiently large doses, it will grow in the rat for the first ten days, although, as a rule, not as rapidly as the rat strain. The tumour resulting from this first passage through rats now consists of tumour cells of mouse origin and of stroma cells of rat origin. If this tumour is again inoculated into rats, the animals receive tumour cells of mouse origin and stroma cells of rat origin, so that the conditions are now the same as when the rat strain has been used for the preliminary inoculation. If the difference between the immunizing power of the mouse strain and of the rat strain still persists after the mouse strain has been subjected to one, or even more passages through rats, such difference must then be attributed to differences in the tumour parenchyma. charts given in Plates IV and V. In most of these experiments the Jensen rat sarcoma did not grow very well in the control rats. In Experiment 32 (Plate IV), in which it grew well in the controls, there was.a definite but slight immunity in the immunized rats, but the immunity v;as not ·gte~i~lO-:f~a.n that produced by the mouse strain which had not undergone passage "tnrough a {}it. and markedly less than that produced hi· me rat strain. A :gli,ght-, inimllilUf was observed also in Experiment 34, in~nichthe Jensen rai:sai~brna.:ttid 'not grow well in the controls. In Experiments 35 and 36: {fIaite :IV) the Jensen rat sarcoma grew better in the animals which had ··recen-ed·a preliminary inoculation with the mouse strain passed once or twice through rats than in the control rats where the growth of the Jensen rat sarcoma was bad, and this phenomenon was observed even more distinctly in Experiments 30 and 31 (Plate V) in which the preliminary inoculation had been made with necrotic tissue from the mouse strain passaged through rats. This phenomenon-the opposite of immunity-has been described in the literature as "hypersusceptibility." In Woglom's review (1929) he refers to this phenomenon as one" difficult to demonstrate, if indeed it exists at all." It is interesting to note that it has been stated to occur after a preliminary inoculation with heterologous tissue or with autolysates of tumors. As in the experiments carried out in the course 
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Rats Since the mouse strain of the Ehrlich tumour after a passage through rats still shows the same difference from the rat strain, the conclusion arrived at before is justified, that the cells of the rat strain have undergone a biological alteration as the result of the prolonged propagation in rats.
SUMMARY AND CONCLUSION
A transplantable mouse carcinoma known as "the Ehrlich carcinoma" has been propagated continuously for seven years in rats. It is one of the most rapidly growing, if not the most rapidly growing transplantable mouse tumour. Histologically, it consists of undifferentiated round cells irregularly arranged without any definite structure, and with only a feeble stroma reaction. The heterotransplantability of this strain is due, probably, to its exceptionally vigorous growth, and partly to the feebleness of its stroma reaction. The immunity reactions of this tumour, both of the strain propagated continuously in rats and the strain growing in mice, have been studied. As such a tumour strain has not been known before, these investigations deal with a hitherto unexplored subject.
Using the rat strain as the test inoculation, it was found that it could not be transplanted in rats previously treated with mouse tissue, whether normal or cancerous, while a previous treatment of rats with rat tissue did not produce any such resistance. Using this method as a criterion, the tumours of the Ehrlich rat strain behaved, therefore, as if they were still composed of mouse cells. This conclusion is confirmed by the general biological behaviour of the rat strain, for which the mouse organism always presents a more favourable soil than the rat organism. It can be readily transferred back to mice, even by the inoculation of small doses. In mice it never regresses and grows so vigorously that no resistance can be induced in mice to its transplantation; whereas in rats its growth ceases after ten days, and regression sets in. The propagation of this rat strain represents, therefore, the first example of a heterotransplantation of malignant cells of the mouse continued over many years in adult rats without any transference of the property of malignancy to the cells of the rats which served as hosts. Resistance against heterotransplantation can be induced by the previous inoculation of tissue homologous to the tumour-in this case mouse tissue-but not of tissue homologous to the host, in this case rat tissue.
A biological difference exists between the mouse strain and the rat strain of the Ehrlich carcinoma. Rats in which the rat strain had grown and had regressed were resistant to a subsequent transplantation of tumours of rat origin, such as the Jensen rat sarcoma and the Walker rat carcinoma; while rats in which the mouse strain had grown and regressed were much less resistant. This is interpreted as showing that the cells of the Ehrlich carcinoma, as a result of the continued propagation in the rat, had undergone a biological alteration. They had adapted themselves to the environment of a rat organism, and the rat-grown strain now represents a separate sub-strain of the Ehrlich mouse carcinoma. NOTE: It gives me great pleasure to acknowledge my indebtedness to Dr. W. E. Gye for permission to carry out the greater part of this investigation in his laboratory and to Dr. W. Cramer for his valuable help and advice.
